Here, we demonstrated that the non-metabolic activity of 6PGD regulates p53 protein stability to promote CRC tumor growth and migration through the ALKBH5-MDM2-p53-CCNA2/HMGA2 axis. The gene discussed is TP53; the disease is colorectal carcinoma.